Position in LLY
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$14,490,315
+$4,245,917 QoQ
Shares Held
12,081
+8.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.21%
of 13F equity value
Holder Rank
#1,052
of 4,605 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CENTAURUS FINANCIAL, INC. holds $28,490,833 across 13 Drug Manufacturers - General names. LLY ranks #1 (50.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
12,081 | $14,490,315 | |
| 2 | ABBV |
AbbVie Inc.
|
13,295 | $3,345,553 | |
| 3 | JNJ |
Johnson & Johnson
|
12,384 | $3,145,164 | |
| 4 | MRK |
Merck & Co., Inc.
|
11,912 | $1,530,692 | |
| 5 | AMGN |
Amgen Inc
|
3,413 | $1,235,915 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,694 | $972,059 | |
| 7 | NVS |
Novartis AG
|
5,748 | $900,826 | |
| 8 | PFE |
Pfizer Inc
|
36,772 | $885,469 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,490,315 | 12,081 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $10,244,398 | 11,138 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $12,106,271 | 11,265 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $10,176,131 | 13,337 | Shares | Sole | 2025-11-20 | |
| 2025-06-30 | $10,219,638 | 13,110 | Shares | Sole | 2025-08-29 | |
| 2025-03-31 | $11,336,440 | 13,726 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,146,136 | 14,438 | Shares | Sole | 2025-03-12 | |
| 2024-09-30 | $10,155,530 | 11,463 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,521,912 | 6,099 | Shares | Sole | 2024-09-23 | |
| 2024-03-31 | $2,344,771 | 3,014 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,167,588 | 2,003 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $1,057,071 | 1,968 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,244,203 | 2,653 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $1,449,575 | 4,221 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $1,763,348 | 4,820 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,252,011 | 3,872 | Shares | Sole | 2022-12-05 | |
| 2022-06-30 | $1,104,975 | 3,408 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $663,232 | 2,316 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $641,935 | 2,324 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $457,710 | 1,981 | Shares | Sole | 2021-11-12 | |
| 2021-03-31 | $115,081 | 616 | Shares | Sole | 2021-04-30 | |
| No filing history on record for this holder in this stock. | ||||||